Abrdn PLC Ionis Pharmaceuticals Inc Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Abrdn PLC holds 303,274 shares of IONS stock, worth $12.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

303,274

Previous 246,917 22.82%

Holding current value

$12.2 Million

Previous $11.8 Million 3.24%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$40.06 - $51.86 $2.26 Million - $2.92 Million	56,357 Added 22.82%	303,274 $12.1 Million
Q2 2024 Aug 09, 2024	BUY	$36.45 - $47.7 $1 Million - $1.31 Million	27,496 Added 12.53%	246,917 $11.8 Million
Q1 2024 May 08, 2024	BUY	$42.03 - $53.55 $3.49 Million - $4.44 Million	83,002 Added 60.84%	219,421 $9.51 Million
Q4 2023 Jan 31, 2024	BUY	$43.39 - $51.63 $5.92 Million - $7.04 Million	136,419 New	136,419 $6.9 Million
Q2 2021 Aug 10, 2021	SELL	$34.54 - $47.25 $179,504 - $245,558	-5,197 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$42.51 - $63.78 $17,216 - $25,830	405 Added 8.45%	5,197 $234,000
Q4 2020 Feb 10, 2021	BUY	$45.3 - $60.27 $24,597 - $32,726	543 Added 12.78%	4,792 $271,000
Q3 2020 Oct 21, 2020	SELL	$47.45 - $62.95 $171,769 - $227,879	-3,620 Reduced 46.0%	4,249 $202,000
Q2 2020 Aug 10, 2020	BUY	$46.85 - $61.05 $843 - $1,098	18 Added 0.23%	7,869 $464,000
Q1 2020 May 13, 2020	BUY	$41.6 - $63.4 $8,860 - $13,504	213 Added 2.79%	7,851 $372,000
Q4 2019 Feb 18, 2020	BUY	$53.85 - $65.27 $7,108 - $8,615	132 Added 1.76%	7,638 $461,000
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $1.2 Million - $1.46 Million	-20,294 Reduced 73.0%	7,506 $450,000
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $1.73 Million - $2.39 Million	27,800 New	27,800 $1.79 Million

Others Institutions Holding IONS

# of Institutions

390

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.73B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account